2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

C21H27N10O8PS — CID 137123416

IUPAC2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2OP(O)(=S)OCC[C@H]2O[C@@H](c3cnc4c(N)ncnn34)C[C@@H]2O)c(=O)[nH]1
InChIInChI=1S/C21H27N10O8PS/c22-16-18-24-5-10(31(18)27-7-25-16)13-4-11(33)12(38-13)1-2-36-40(35,41)39-14-3-9(6-32)37-20(14)30-8-26-15-17(30)28-21(23)29-19(15)34/h5,7-9,11-14,20,32-33H,1-4,6H2,(H,35,41)(H2,22,25,27)(H3,23,28,29,34)/t9-,11-,12+,13+,14+,20+,40?/m0/s1
InChIKeyJQXSNTKJNGRFPP-OZHRNSCWSA-N
MW610.55 g/mol
LogP-1.10
Rot. Bonds9

About 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one (PubChem CID 137123416) has the molecular formula C21H27N10O8PS and a molecular weight of 610.55 g/mol. Its IUPAC name is 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one.

Molecular Properties

Compound Name2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
PubChem CID137123416
Molecular FormulaC21H27N10O8PS
Molecular Weight610.55 g/mol
Exact Mass610.15
IUPAC Name2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2OP(O)(=S)OCC[C@H]2O[C@@H](c3cnc4c(N)ncnn34)C[C@@H]2O)c(=O)[nH]1
InChIInChI=1S/C21H27N10O8PS/c22-16-18-24-5-10(31(18)27-7-25-16)13-4-11(33)12(38-13)1-2-36-40(35,41)39-14-3-9(6-32)37-20(14)30-8-26-15-17(30)28-21(23)29-19(15)34/h5,7-9,11-14,20,32-33H,1-4,6H2,(H,35,41)(H2,22,25,27)(H3,23,28,29,34)/t9-,11-,12+,13+,14+,20+,40?/m0/s1
InChIKeyJQXSNTKJNGRFPP-OZHRNSCWSA-N
XLogP-1.10
TPSA256.30 Ų
H-Bond Donors6
H-Bond Acceptors17
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500610.55
LogP ≤ 5-1.10
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one?
The IUPAC name of 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one (CID 137123416) is 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one.
What is the SMILES notation for 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one?
The canonical SMILES for 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one is Nc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2OP(O)(=S)OCC[C@H]2O[C@@H](c3cnc4c(N)ncnn34)C[C@@H]2O)c(=O)[nH]1.
What is the InChIKey of 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one?
The InChIKey is JQXSNTKJNGRFPP-OZHRNSCWSA-N. The full InChI is InChI=1S/C21H27N10O8PS/c22-16-18-24-5-10(31(18)27-7-25-16)13-4-11(33)12(38-13)1-2-36-40(35,41)39-14-3-9(6-32)37-20(14)30-8-26-15-17(30)28-21(23)29-19(15)34/h5,7-9,11-14,20,32-33H,1-4,6H2,(H,35,41)(H2,22,25,27)(H3,23,28,29,34)/t9-,11-,12+,13+,14+,20+,40?/m0/s1.
What are the key properties of 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one?
2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one has a molecular weight of 610.55 g/mol, XLogP of -1.10, 9 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-9-[(2R,3R,5S)-3-[2-[(2R,3S,5R)-5-(4-aminoimidazo[2,1-f][1,2,4]triazin-7-yl)-3-hydroxyoxolan-2-yl]ethoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one is sourced from PubChem (CID 137123416), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).